nVerses Capital, LLC

Position in HIMS — Hims & Hers Health, Inc.

CIK 2011399 WELLINGTON, FL

Position in HIMS

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$245,914

-$13,808 QoQ

Shares Held

7,093

-49.7% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.38%

of 13F equity value

Holder Rank

#331

of 503 holders

Holding Since

Mar 2024

4 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

nVerses Capital, LLC holds $1,009,100 across 5 Drug Manufacturers - Specialty & Generic names. HIMS ranks #2 (24.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LQDA	Liquidia Corp	4,380	$349,217
2	HIMS	Hims & Hers Health, Inc. This page	7,093	$245,914
3	NBIX	Neurocrine Biosciences Inc	1,259	$212,191
4	COLL	Collegium Pharmaceutical, Inc	5,574	$201,778
5	ESPR	Esperion Therapeutics, Inc.	19,453	$0

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$245,914	7,093	-49.7%	Shares	Sole	2026-08-04
2024-09-30	$259,722	14,100	+31.8%	Shares	Sole	2024-10-16
2024-06-30	$216,033	10,700	+3466.7%	Shares	Sole	2024-07-31
2024-03-31	$4,641	300	—	Shares	Sole	2024-04-25
No filing history on record for this holder in this stock.